Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis

被引:156
作者
Moore, MR [1 ]
Schrag, SJ [1 ]
Schuchat, A [1 ]
机构
[1] CDCP, Resp Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA
关键词
D O I
10.1016/S1473-3099(03)00577-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Sepsis occurring in the first week of life can be a devastating neonatal problem. Group B streptococci (GBS) and enterobacteriaceae are the main causes of early-onset sepsis in more developed countries. Intrapartum antimicrobial prophylaxis (IAP) has lowered the incidence of early-onset GEIS sepsis by 50-80%. However, there are concerns that the use of IAP may select for infections caused by enterobacteriaceae, including some strains resistant to antimicrobials. We explored potential associations between IAP use and changes in the causes of early-onset sepsis. We concluded that there have been substantial declines in the incidence of early-onset infections due to GBS and, in some settings, other bacteria. Increases in the frequencies of non-GBS or anti microbial-resistant early-onset sepsis have been limited to preterm, low-birthweight, or very-low-birthweight neonates. We propose systematic monitoring of early-onset sepsis, coupled with targeted research, to inform periodic reassessment of prevention strategies.
引用
收藏
页码:201 / 213
页数:13
相关论文
共 72 条
[1]   Management of asymptomatic term neonates whose mothers received intrapartum antibiotics .2. Diagnostic tests and management strategies [J].
Allen, SR .
CLINICAL PEDIATRICS, 1997, 36 (11) :617-624
[2]  
*AM COLL OBST GYN, 1992, GROUP B STREPT INF P
[3]   Group B streptococci causing neonatal bloodstream infection: Antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere [J].
Andrews, JI ;
Diekema, DJ ;
Hunter, SK ;
Rhomberg, PR ;
Pfaller, MA ;
Jones, RN ;
Doern, GV .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 183 (04) :859-862
[4]  
[Anonymous], 1992, Pediatrics, V90, P775
[5]  
[Anonymous], 2002, CAN MED ASSOC J, V166, P928
[6]  
[Anonymous], PREV EARL ONS GROUP
[7]   Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib [J].
Baker, CJ ;
Paoletti, LC ;
Wessels, MR ;
Guttormsen, HK ;
Rench, MA ;
Hickman, ME ;
Kasper, DL .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (01) :142-150
[8]   Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women [J].
Baker, CJ ;
Paoletti, LC ;
Rench, MA ;
Guttormsen, HK ;
Carey, VJ ;
Hickman, ME ;
Kasper, DL .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (04) :1129-1138
[9]   Early-onset neonatal sepsis in the era of group B streptococcal prevention [J].
Baltimore, RS ;
Huie, SM ;
Meek, JI ;
Schuchat, A ;
O'Brien, KL .
PEDIATRICS, 2001, 108 (05) :1094-1098
[10]   Effect of antibiotic therapy in preterm premature rupture of the membranes on neonatal mortality and morbidity [J].
Bar, J ;
Maayan-Metsger, A ;
Hod, M ;
Ben Rafael, Z ;
Orvieto, R ;
Shalev, Y ;
Sirota, L .
AMERICAN JOURNAL OF PERINATOLOGY, 2000, 17 (05) :237-241